Associate Director, Global Pricing Strategy & Analytics

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Associate Director, Global Pricing Strategy & Analytics will play a critical role in shaping and executing global pricing strategies across the portfolio. This individual will lead the development of pricing frameworks, provide advanced analytics, and generate insights to support value optimization and market access decisions. The role requires strong cross-functional collaboration with Market Access, Commercial, Finance, HEOR, and Regional teams to ensure pricing strategies are aligned with business objectives and external market dynamics. Key Responsibilities: Global Pricing Strategy Support the development and execution of global pricing strategies for pipeline products across key markets. Establish pricing guidance, guardrails, and launch sequencing strategies to optimize global value. Evaluate pricing scenarios considering payer dynamics, competitive landscape, and regulatory constraints. Support early asset strategy by integrating pricing considerations into clinical and commercial planning. Analytics & Insights Design and deliver advanced pricing and access analytics, including price-volume trade-offs, corridor analyses, and international reference pricing (IRP) impact. Develop and maintain pricing models to inform decision-making at global and regional levels. Generate insights from real-world data, market research, and analog products to support pricing decisions. Monitor pricing performance and identify risks/opportunities post-launch. Governance & Execution Drive pricing governance processes, including global price approvals and exception management. Ensure compliance with global pricing policies and external regulations. Partner with regional and country teams to support local price setting and negotiations. Cross-Functional Collaboration Collaborate closely with Market Access, HEOR, Commercial, Finance, and Legal teams. Align pricing strategies with value proposition, evidence generation, and reimbursement pathways. Provide strategic input into business development opportunities, including licensing and acquisitions. Capability Building Develop global pricing infrastructure including systems, tools, and analytical platforms. Contribute to the development of pricing frameworks, dashboards, and best practices. Required Skills, Experience and Education: Education & Experience Bachelor’s degree required; advanced degree (MBA, MPH, PhD, PharmD, or equivalent) preferred. 6+ years of experience in pharmaceutical/biotech industry, with strong focus on pricing, market access, or commercial analytics. Experience in global pricing strategy and launch pricing preferred. Skills & Competencies Deep understanding of global pricing, reimbursement systems, and payer dynamics. Strong analytical and quantitative skills with experience in pricing modeling and data analysis. Ability to translate complex data into clear strategic recommendations. Excellent communication and stakeholder management skills. Proven ability to work cross-functionally in a global, matrixed environment. High level of business acumen and strategic thinking. Preferred Skills: Experience with oncology or specialty therapeutics. Familiarity with international reference pricing (IRP), health techno